Opening book details…
Can I read Higher aqueous levels of resistin and lipocalin-2 indicated worse visual improvement following anti-VEGF therapy in patients with retinal vein occlusion. on EtoBox?
Higher aqueous levels of resistin and lipocalin-2 indicated worse visual improvement following anti-VEGF therapy in patients with retinal vein occlusion. by Luo, Yong; Wan, Jianbo; Luo, Chang; Liu, HengWei; Zhou, YuFan; Chen, Juan; Duan, Yiqin; Ning, Xiangyan; Zhou, Zengchao; Wang, Kehua; Li, Jun; Xu, Heping; Chen, ZhongPing is a Medicine article available to read on EtoBox.
What is Higher aqueous levels of resistin and lipocalin-2 indicated worse visual improvement following anti-VEGF therapy in patients with retinal vein occlusion. about?
## Purpose: The aim of this study was to investigate the aqueous humor levels of elastase-2, lactoferrin, lipocalin-2 (lcn-2), resistin, and thrombospondin-1 (tsp-1) in patients with retinal vein occlusion (rvo) and their relationship with visual prognosis following intravitreal anti-vascular endothelial growth factor (vegf) therapy. ## Materials and methods: 52 rvo patients (23 cases of central retinal vein occlusion (crvo) and 29 cases of branch retinal vein occlusion (brvo)) and 20 cases of senile cataract were enrolled in this study. all rvo patients underwent fundus examinations before and 6-8 months after intravitreal anti-vegf treatment. five milliliters of blood were collected from rvo patients before treatment for the measurement of lipids and coagulation factors. sixty microliters of aqueous humor were collected during intravitreal injection of anti-vegf or during cataract surgery. the levels of elastase-2, lactoferrin, lcn-2, resistin, and tsp-1 in aqueous humor were determined by luminex xmap multiple analysis. ## Results: The aqueous levels of resistin and lcn-2 were significantly higher but the level of tsp-1 was significantly lower in rvo patients compared to control
Who reads Higher aqueous levels of resistin and lipocalin-2 indicated worse visual improvement following anti-VEGF therapy in patients with retinal vein occlusion.?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Luo, Yong; Wan, Jianbo; Luo, Chang; Liu, HengWei; Zhou, YuFan; Chen, Juan; Duan, Yiqin; Ning, Xiangyan; Zhou, Zengchao; Wang, Kehua; Li, Jun; Xu, Heping; Chen, ZhongPing
- Publisher
- Informa plc; Informa UK (Informa Healthcare); Taylor & Francis; Swets & Zeitlinger Publishers; Informa UK Limited (ISSN 6854-1423)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)